389819945-NANDA-I-2018-2020-pt-es-pdf

Namasivayam S, Kalra MK, Torres WE, Small WC. Adverse reactions to intravenous
iodinated contrast media: a primer for radiologists. Emerg Radiol. 2006; 12(5):210– 215
Reddan D. Patients at high risk of adverse events from intravenous contrast media after
computed tomography examination. Eur J Radiol. 2007; 62(Supplement):26–32
Riedl MA, Casillas AM. Adverse drug reactions: types and treatment options. Am Fam Physician.
2003; 68(9):1781–1790
Siddiqi NH. (2008). Contrast medium reactions, recognition and treatment. Emedicine.
Retrieved from http://www.emedicine.com/Radio/topic864.h tm
Schild HH, Kuhl CK, Hübner-Steiner U, Böhm I, Speck U. Adverse events after unenhanced
and monomeric and dimeric contrast-enhanced CT: a prospective randomized controlled
trial. Radiology. 2006; 240(1):56–64 Singh J, Daftary A. Iodinated contrast media and their
adverse reactions. J Nucl Med Technol. 2008; 36(2):69–74, quiz 76–77
Stacul F. Managing the risk associated with use of contrast media for computed
tomography. Eur J Radiol. 2007; 62(1):33–37
Thomsen HS, Morcos SK, Contrast Media Safety Committee of European Society of Urogenital
Radiology. Management of acute adverse reactions to contrast media. Eur Radiol. 2004;
14(3):476–481
Valls C, Andía E, Sánchez A, Moreno V. Selective use of low-osmolality contrast media in
computed tomography. Eur Radiol. 2003; 13(8):2000– 2005
Vervloet D, Durham S. Adverse reactions to drugs. BMJ. 1998; 316(7143):1511–1514
Webb JA, Stacul F, Thomsen HS, Morcos SK, Members Of The Contrast Media Safety
Committee Of The European Society Of Urogenital Radiology. Late adverse reactions
to intravascular iodinated contrast media. Eur Radiol. 2003; 13(1):181–184